Common use of Publications Regarding Results of the Research Program Clause in Contracts

Publications Regarding Results of the Research Program. Neither Party may publish, or otherwise publicly present or announce results of the Research Programs or Development of ADCs or Licensed Products hereunder either orally or in writing (a “Publication”) without complying with the provisions of this Section 9.5. A Party wishing to make a Publication will provide the other Party with a copy of the proposed Publication. The other Party shall have [***] Business Days from receipt of a proposed Publication to provide comments or proposed changes to the publishing Party. The publishing Party shall take into account the comments or proposed changes made by the other Party on any Publication and shall agree to designate employees or others acting on behalf of the other Party as co-authors on any Publication describing results to which such persons have contributed in accordance with standards applicable to authorship of scientific publications. If the other Party reasonably determines that the Publication would entail the public disclosure of such Party’s Confidential Information or of a patentable invention upon which a patent application should be filed prior to any such disclosure, submission of the concerned Publication to Third Parties shall be delayed for such period as may be reasonably necessary for deleting any such Confidential Information of the other Party (if the other Party has requested deletion thereof from the proposed Publication), or the drafting and filing of a patent application covering such invention, provided such additional period shall not exceed [***] Business Days from the date the publishing Party first provided the proposed Publication to the other Party. Notwithstanding anything to the contrary in the foregoing, with respect to any Publications by investigators or other Third Parties, such materials shall be subject to review under this Section 9.5 only to the extent that Licensee has the right and ability (after using Commercially Reasonable Efforts) to do so. Without limitation of the foregoing, MTI’s rights to make any Publication will be limited to the results of a Research Program and after exercise of an Option hereunder, MTI shall not make any Publication with respect to the applicable Research Program without Licensee’s prior written consent.

Publications Regarding Results of the Research Program. Neither Party may publish, or otherwise publicly present or announce results of the Research Programs or Development of ADCs or Licensed Products hereunder either orally or in writing (a “Publication”) without complying with the provisions of this Section 9.57.5. A Party wishing to make a Publication will provide the other Party with a copy of the proposed Publication. The other Party shall will have [***] Business Days days from receipt of a proposed Publication to provide comments or proposed changes to the publishing Party. The publishing Party shall will take into account the comments or proposed changes made by the other Party on any Publication and shall will agree to designate employees or others acting on behalf of the other Party as co-authors on any Publication describing results to which such persons have contributed in accordance with standards applicable to authorship of scientific publications. If the other Party reasonably determines that the Publication would entail the public disclosure of such Party’s Confidential Information or of a patentable invention upon which a patent application should be filed prior to any such disclosure, submission of the concerned Publication to Third Parties shall will be delayed for such period as may be reasonably necessary for deleting any such Confidential Information of the other Party (if the other Party has requested deletion thereof from the proposed Publication), or the drafting and filing of a patent application covering or claiming such invention, provided such additional period shall will not exceed [***] Business Days days from the date the publishing Party first provided the proposed Publication to the other Party. Notwithstanding anything to the contrary in the foregoing, with respect to any Publications by investigators or other Third Partiesinvestigators, such materials shall will be subject to review by Mersana under this Section 9.5 7.5 only to the extent that Licensee Merck has the right to review such Publications, and ability (after using Merck will use Commercially Reasonable Efforts) Efforts to do so. Without limitation of the foregoing, MTI’s rights to make any Publication will be limited to the results of a Research Program and after exercise of an Option hereunder, MTI shall not make any Publication with respect to the applicable Research Program without Licensee’s prior written consentobtain such right.

Publications Regarding Results of the Research Program. Neither Party may publish, or otherwise publicly present or announce results of the Research Programs or Development of ADCs or Licensed Products hereunder Program either orally or in writing writing, or use the other Party’s name or trademarks in any publication, research report or study (each, a “Publication”) without complying with the provisions of this Section 9.58.5. A Any Party wishing to make a Publication will provide shall send notice to the other Party. No Publication shall contain any Confidential Information of the other Party with a copy without the consent and approval of the proposed Publicationother Party, which may be granted or withheld in the sole discretion of a Party. The other Party shall have [***] Business Days from receipt of a proposed Publication to provide comments or and/or proposed changes to the publishing Party. The publishing Party shall take into account the comments or and/or proposed changes made by the other Party on any Publication and shall agree to designate employees or others acting on behalf of the other Party as co-authors on any Publication describing results to which such persons have contributed in accordance with standards applicable to authorship of scientific publications. If the other Party reasonably determines that the Publication would entail the public disclosure of such Party’s Confidential Information or and/or of a patentable invention upon which a patent application should be filed prior to any such disclosure, submission of the concerned Publication to Third Parties shall be delayed for such period as may be reasonably necessary for deleting [***] any such Confidential Information of the other Party (if the other Party has requested deletion thereof from the proposed Publication), or and/or the drafting and filing of a patent application covering such invention, provided such additional period shall not exceed [***] Business Days from the date the publishing Party first provided the proposed Publication to the other Party. Notwithstanding anything to In the contrary in the foregoing, with respect to event of any Publications by investigators or other Third Parties, such materials shall be subject to review disagreement under this Section 9.5 only to 8.5, any dispute shall be resolved in the extent that Licensee has the right and ability (after using Commercially Reasonable Efforts) to do so. Without limitation of the foregoing, MTI’s rights to make any Publication will be limited to the results of a Research Program and after exercise of an Option hereunder, MTI shall not make any Publication with respect to the applicable Research Program without Licensee’s prior written consentmanner specified in Section 19.3.

Publications Regarding Results of the Research Program. Neither Party may publish, or otherwise publicly present or announce results of the Research Programs or Development of ADCs or Licensed Products hereunder either orally or in writing (a “Publication”) without complying with the provisions of this Section 9.57.5. A Party wishing to make a Publication will provide the other Party with a copy of the proposed Publication. The other Party shall will have [***] Business Days days from receipt of a proposed Publication to provide comments or proposed changes to the publishing Party. The publishing Party shall will take into account the comments or proposed changes made by the other Party on any Publication and shall will agree to designate employees or others acting on behalf of the other Party as co-authors on any Publication describing results to which such persons have contributed in accordance with standards applicable to authorship of scientific publications. If the other Party reasonably determines that the Publication would entail the public disclosure of such Party’s Confidential Information or of a patentable invention upon which a patent application should be filed prior to any such disclosure, submission of the concerned Publication to Third Parties shall will be delayed for such period as may be reasonably necessary for deleting any such Confidential Information of the other Party (if the other Party has requested deletion thereof from the proposed Publication), or the drafting and filing of a patent application covering or claiming such invention, provided such additional period shall will not exceed [***] Business Days days from the date the publishing Party first provided the proposed Publication to the other Party. Notwithstanding anything to the contrary in the foregoing, with respect to any Publications by investigators or other Third Partiesinvestigators, such materials shall will be subject to review by Mersana under this Section 9.5 7.5 only to the extent that Licensee Merck has the right to review such Publications, and ability (after using Merck will use Commercially Reasonable Efforts) Efforts to do so. Without limitation of the foregoing, MTI’s rights to make any Publication will be limited to the results of a Research Program and after exercise of an Option hereunder, MTI shall not make any Publication with respect to the applicable Research Program without Licensee’s prior written consentobtain such right.

Publications Regarding Results of the Research Program. Neither Party may publish, or otherwise publicly present or announce results of the Research Programs or Development of ADCs or Licensed Products hereunder either orally or in writing (a “Publication”) without complying with the provisions of this Section 9.57.5. A Party wishing to make a Publication will provide the other Party with a copy of the proposed Publication. The other Party shall will have [***] Business Days days from receipt of a proposed Publication to provide comments or proposed changes to the publishing Party. The publishing Party shall will take into account the comments or proposed changes made by the other Party on any Publication and shall will agree to designate employees or others acting on behalf of the other Party as co-authors on any Publication describing results to which such persons have contributed in accordance with standards applicable to authorship of scientific publications. If the other Party reasonably determines that the Publication would entail the public disclosure of such Party’s Confidential Information or of a patentable invention upon which a patent application should be filed prior to any such disclosure, submission of the concerned Publication to Third Parties shall will be delayed for such period as may be reasonably necessary for deleting any such Confidential Information of the other Party (if the other Party has requested deletion thereof from the proposed Publication), or the drafting and filing of a patent application covering or claiming such invention, provided such additional period shall will not exceed [***] Business Days days from the date the publishing Party first provided the proposed Publication to the other Party. Notwithstanding anything to the contrary in the foregoing, with respect to any Publications by investigators or other Third Partiesinvestigators, such materials shall will be subject to review by Mersana under this Section 9.5 7.5 only to the extent that Licensee Merck has the right to review such Publications, and ability (after using Merck will use Commercially Reasonable Efforts) Efforts to do soobtain such right. Without limitation [***] Portions of this exhibit have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the foregoing, MTI’s rights to make any Publication will be limited to the results of a Research Program and after exercise of an Option hereunder, MTI shall not make any Publication with respect to the applicable Research Program without Licensee’s prior written consentCommission.

Publications Regarding Results of the Research Program. Neither Party may publish, or otherwise publicly present or announce results of the Research Programs or Development of Licensed ADCs or Licensed Products hereunder either orally or in writing (a “Publication”) without complying with the provisions of this Section 9.58.6. A Party wishing to make a Publication will provide the other Party with a copy of the proposed Publication. The other Party shall will have [***] Business Days from receipt of a proposed Publication to provide comments or proposed changes to the publishing Party. The publishing Party shall will take into good faith account the comments or proposed changes made by the other Party on any Publication and shall will agree to designate employees or others acting on behalf of the other Party as co-authors on any Publication describing results to which such persons have contributed in accordance with standards applicable to authorship of scientific publications. If the other Party reasonably determines that the Publication would entail the public disclosure of such Party’s Confidential Information or of a patentable invention upon which a patent application should be filed prior to any such disclosure, submission of the concerned Publication to Third Parties shall will be delayed for such period as may be reasonably necessary for deleting any such Confidential Information of the other Party (if the other Party has requested deletion thereof from the proposed Publication), or the drafting and filing of a patent application covering or claiming such invention, provided such additional period shall will not exceed [***] Business Days from the date the publishing Party first provided the proposed Publication to the other Party. Notwithstanding anything to the contrary in the foregoing, with respect to any Publications by investigators or other Third Partiesinvestigators, such materials shall will be subject to review by Xxxxxxx under this Section 9.5 8.6 only to the extent that Licensee ATSA has the right to review such Publications, and ability (after using XXXX will use Commercially Reasonable Efforts) Efforts to do soobtain such right. Without limitation of the foregoingFor clarity, MTI’s rights to Mersana may make any Publication will be limited to the results of a Research Program publications, presentations and after exercise of an Option hereunder, MTI shall not make any Publication announcements with respect to the applicable Research Program Mersana Technology and Mersana IP without Licensee’s the prior written consentconsent of ATSA and without complying with the process outlined in this Section 8.6; provided that, such publication, presentation or announcement does not include the results of the Research Programs or Development of Licensed ADCs or Licensed Products or other Confidential Information of ATSA hereunder.